Related Experiment Video
Updated: Oct 4, 2025

Optimized Management of Endovascular Treatment for Acute Ischemic Stroke
Published on: January 18, 2018
Invasive dental treatment and acute vascular events: A systematic review and meta-analysis
Shailly Luthra1, Marco Orlandi1, Yago Leira1,2,3
1Periodontology Unit, UCL Eastman Dental Institute, UCL, London, UK.
Background:
Acute infection/inflammation increases the risk of acute vascular events (AVEs). Invasive dental treatments (IDTs) trigger short-term acute inflammation.
Purpose:
The aim of this work is to critically appraise the evidence linking IDTs and AVEs.
Data Sources:
Six bibliographical databases were searched up to 31 August 2021. A systematic review following PRISMA guidelines was performed.
Study Selection:
Intervention and observational studies reporting any AVEs following IDT were included.
Data Extraction:
Two reviewers independently extracted data and rated the quality of studies. Data were pooled using fixed-effect, inverse variance weights analysis.
Risk Of Bias:
Risk of bias was assessed by the Newcastle-Ottawa Quality Assessment Scale for observational studies and the Cochrane Handbook-Rob 2.0 for randomized controlled trials.
Data Synthesis:
In 3 out of 16 clinical studies, a total of 533,175 participants, 124,344 myocardial infarctions, and 327,804 ischaemic strokes were reported. Meta-analysis confirmed that IDT did not increase incidence ratios (IR) for combined vascular events either at 1-4 weeks (IR of 1.02, 95% CIs: 0.92 to 1.13) and at 5-8 weeks (IR of 1.04, 95% CIs: 0.97 to1.10) after treatment.
Limitations:
A high level of heterogeneity (study designs and time point assessments) was found.
Conclusion:
Patients who received IDT exhibited no substantial increase in vascular risk over 8 weeks post treatment.
Related Concept Videos
Venous Thrombosis III: Interprofessional Care
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Endocarditis III: Medical Management
Coronary Artery Disease V: Interprofessional Care
Aneurysm III: Interprofessional Care
Acute Coronary Syndrome V: Nursing Management

